« Back
Home /
CK-19 Polyclonal Antibody

CK-19 Polyclonal Antibody

Item no.	E-AB-70083-200
Manufacturer	Elabscience
Amount	200 uL
Quantity options	120 uL 200 uL 60 uL
Category	Oncology Antibodies Cell Biology Cytoskeleton Immunohistochemistry Western Blot Primary Antibodies Intermediate filaments By Organ Bladder Cancer
Type	Antibody Polyclonal
Applications	WB, IHC
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host	Rabbit
Isotype	IgG
Conjugate/Tag	Unconjugated
Citations	https://www.sciencedirect.com/science/article/pii/S1567576919326438 https://www.spandidos-publications.com/10.3892/mmr.2021.12571
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	40 kDa keratin intermediate filament, CK 19, CK-19, CK19, Cytokeratin 19, Cytokeratin-19, K19, K1C19, K1CS, Keratin 19, Keratin type I 40 kD, Keratin type I 40kD, Keratin type I cytoskeletal 19, Keratin, type I cytoskeletal 19, Keratin, type I, 40 kd, Keratin-19, KRT19, MGC15366
Similar products	Cytokeratin-19, KRT19, Keratin 19, Keratin, CK-19, type I cytoskeletal 19, Keratin-19, K19, CK19, Cytokeratin 19, CK 19, type I, K1CS, MGC15366, 40 kDa keratin intermediate filament, Keratin type I 40 kD, Keratin type I cytoskeletal 19, K1C19, Keratin type I 40kD, 40 kd
Shipping condition	Cool pack
Hazard information	Comply with cargo safety certificate
Available
Manufacturer - Category	Primary Antibodies
Manufacturer - Targets	CK-19
Shipping Temperature	The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions	Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight	44kDa
Observed Molecular Weight	44kDa
Research Areas	Cancer, Signal Transduction
Background	The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells. KRT19, one of type I keratins, is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. Due to its high sensitivity, KRT19 is the most used marker for detection of tumor cells disseminated in lymph nodes, peripheral blood, and bone marrow of breast cancer patients. This antibody, generated against full length KRT19 protein, also recognizes KRT17, another type I keratin homologous to KRT19. KRT17 is used as a marker for trauma.
Concentration	0.66 mg/mL
Buffer	PBS with 0.02% sodium azide, 1% protective protein and 50% glycerol, pH7.4
Purification Method	Affinity purification
Recommended Dilution	WB 1:500-1:2000; IHC 1:200-1:800
Abbreviation	CK-19
Clonality	Polyclonal
Immunogen	KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 19
Category ID III	Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.